CSL Limited (OTCMKTS:CSLLY – Get Free Report)’s stock price hit a new 52-week high on Tuesday . The company traded as high as $106.82 and last traded at $103.40, with a volume of 18469 shares changing hands. The stock had previously closed at $103.09.
CSL Stock Performance
The business’s 50-day moving average is $97.53 and its two-hundred day moving average is $94.73.
About CSL
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.
Recommended Stories
- Five stocks we like better than CSL
- Find and Profitably Trade Stocks at 52-Week Lows
- Viking Therapeutics: Pharma Stock Soars on Positive Earnings
- What is the S&P 500 and How It is Distinct from Other Indexes
- Top 3 Small Cap Stocks Emerging as Rotation Winners
- Why Invest in High-Yield Dividend Stocks?
- Bargain Alert: 3 Stocks Worth Watching While The Market Cools
Receive News & Ratings for CSL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSL and related companies with MarketBeat.com's FREE daily email newsletter.
